CN1279932C - 贞芪扶正药制备方法改进 - Google Patents
贞芪扶正药制备方法改进 Download PDFInfo
- Publication number
- CN1279932C CN1279932C CN 200310122216 CN200310122216A CN1279932C CN 1279932 C CN1279932 C CN 1279932C CN 200310122216 CN200310122216 CN 200310122216 CN 200310122216 A CN200310122216 A CN 200310122216A CN 1279932 C CN1279932 C CN 1279932C
- Authority
- CN
- China
- Prior art keywords
- filter
- amount
- water
- filtrate
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 title claims abstract description 50
- 238000000034 method Methods 0.000 title claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 136
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 59
- 239000007788 liquid Substances 0.000 claims abstract description 22
- 239000011347 resin Substances 0.000 claims abstract description 22
- 229920005989 resin Polymers 0.000 claims abstract description 22
- 238000002360 preparation method Methods 0.000 claims abstract description 17
- 238000002347 injection Methods 0.000 claims abstract description 9
- 239000007924 injection Substances 0.000 claims abstract description 9
- 239000000706 filtrate Substances 0.000 claims description 47
- 238000001035 drying Methods 0.000 claims description 38
- 238000003756 stirring Methods 0.000 claims description 34
- 239000000843 powder Substances 0.000 claims description 32
- 239000002244 precipitate Substances 0.000 claims description 27
- 238000005406 washing Methods 0.000 claims description 21
- 238000010828 elution Methods 0.000 claims description 14
- 238000005728 strengthening Methods 0.000 claims description 14
- 239000000284 extract Substances 0.000 claims description 13
- 239000009636 Huang Qi Substances 0.000 claims description 12
- 238000011084 recovery Methods 0.000 claims description 12
- -1 standby Substances 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 9
- 239000006187 pill Substances 0.000 claims description 9
- 239000008187 granular material Substances 0.000 claims description 8
- 239000008215 water for injection Substances 0.000 claims description 8
- 239000003463 adsorbent Substances 0.000 claims description 7
- 230000000274 adsorptive effect Effects 0.000 claims description 7
- 239000012153 distilled water Substances 0.000 claims description 7
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 7
- 229920000053 polysorbate 80 Polymers 0.000 claims description 7
- 238000010992 reflux Methods 0.000 claims description 7
- 230000004927 fusion Effects 0.000 claims description 6
- 229940057995 liquid paraffin Drugs 0.000 claims description 6
- 229920002545 silicone oil Polymers 0.000 claims description 6
- 238000004064 recycling Methods 0.000 claims description 4
- 239000007901 soft capsule Substances 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000009413 insulation Methods 0.000 claims description 3
- 238000002844 melting Methods 0.000 claims description 3
- 230000008018 melting Effects 0.000 claims description 3
- 229940093429 polyethylene glycol 6000 Drugs 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 239000000375 suspending agent Substances 0.000 claims description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 3
- 239000008158 vegetable oil Substances 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 150000004676 glycans Chemical class 0.000 abstract description 3
- 229920001282 polysaccharide Polymers 0.000 abstract description 3
- 239000005017 polysaccharide Substances 0.000 abstract description 3
- 230000006872 improvement Effects 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 229940107666 astragalus root Drugs 0.000 abstract 4
- 241000735234 Ligustrum Species 0.000 abstract 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 2
- GXWUEMSASMVWKO-GNLHUFSQSA-N (4as,6ar,6as,6br,10s,12ar,14br)-10-[(2s,3r,4s,5s)-4,5-dihydroxy-3-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid Chemical compound O([C@@H]1[C@@H](O)[C@@H](O)CO[C@H]1O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CCC2C1(C)C)C)(C)CC[C@]1(CCC(C[C@@H]14)(C)C)C(O)=O)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GXWUEMSASMVWKO-GNLHUFSQSA-N 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000001384 succinic acid Substances 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 12
- 239000002775 capsule Substances 0.000 description 11
- 229940079593 drug Drugs 0.000 description 11
- 239000004480 active ingredient Substances 0.000 description 8
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 6
- SMDOOINVMJSDPS-UHFFFAOYSA-N Astragaloside Natural products C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)=C1 SMDOOINVMJSDPS-UHFFFAOYSA-N 0.000 description 6
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 6
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 6
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 6
- QMNWISYXSJWHRY-XWJCTJPOSA-N astragaloside Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)C4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)CC3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-XWJCTJPOSA-N 0.000 description 6
- 229940100243 oleanolic acid Drugs 0.000 description 6
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 230000006837 decompression Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000012567 medical material Substances 0.000 description 4
- 229920001206 natural gum Polymers 0.000 description 4
- 238000001959 radiotherapy Methods 0.000 description 4
- 239000006286 aqueous extract Substances 0.000 description 3
- 238000007908 dry granulation Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 2
- 208000003468 Ehrlich Tumor Carcinoma Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 206010039491 Sarcoma Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 230000002180 anti-stress Effects 0.000 description 2
- 229960004397 cyclophosphamide Drugs 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000007954 hypoxia Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229940044683 chemotherapy drug Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200310122216 CN1279932C (zh) | 2003-12-15 | 2003-12-15 | 贞芪扶正药制备方法改进 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200310122216 CN1279932C (zh) | 2003-12-15 | 2003-12-15 | 贞芪扶正药制备方法改进 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1628739A CN1628739A (zh) | 2005-06-22 |
CN1279932C true CN1279932C (zh) | 2006-10-18 |
Family
ID=34844449
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200310122216 Expired - Lifetime CN1279932C (zh) | 2003-12-15 | 2003-12-15 | 贞芪扶正药制备方法改进 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1279932C (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103558303A (zh) * | 2013-10-25 | 2014-02-05 | 贵州信邦制药股份有限公司 | 贞芪扶正制剂中齐墩果酸的含量测定方法 |
CN103592391B (zh) * | 2013-11-21 | 2016-01-20 | 贵州信邦制药股份有限公司 | 贞芪扶正制剂中特女贞苷的含量测定方法 |
CN104116786A (zh) * | 2014-07-17 | 2014-10-29 | 贵州信邦制药股份有限公司 | 一种贞芪扶正药物组合物 |
CN104231102A (zh) * | 2014-09-16 | 2014-12-24 | 贵州信邦制药股份有限公司 | 碱提醇沉法提取贞芪组合物中多糖类成分的方法及其产品 |
-
2003
- 2003-12-15 CN CN 200310122216 patent/CN1279932C/zh not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1628739A (zh) | 2005-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1723981A (zh) | 罗汉果提取物用于制备药物辅料的新用途 | |
CN1440778A (zh) | 一种补肾中药 | |
CN100418548C (zh) | 一种药用组合物及其用途 | |
CN102488806A (zh) | 一种肾衰宁中药制剂及其制备方法 | |
CN103599215A (zh) | 一种降糖药物 | |
CN103223104B (zh) | 一种治疗糖尿病的中药组合物及其制备方法 | |
CN1895546B (zh) | 具有治疗和保健功能的枸杞多糖药物组合物 | |
CN1279932C (zh) | 贞芪扶正药制备方法改进 | |
CN111494564A (zh) | 一种复合型保肝解酒片的制备方法 | |
CN1134838A (zh) | 一组富硒北冬虫夏草药品制剂及其制备方法 | |
CN1363290A (zh) | 纳米小儿参术健脾制剂药物及其制备方法 | |
CN1101206C (zh) | 补血口服液及其制备方法 | |
CN1546124A (zh) | 一种注射用生脉冻干粉及其制备方法 | |
CN101028319B (zh) | 防治冠心病的中药复方制剂及制备方法 | |
CN108578578A (zh) | 一种药物组合物及其制备方法 | |
CN1079396A (zh) | 增智药物制剂增智素 | |
CN1814125A (zh) | 四补四泻的地黄制剂 | |
CN1541692A (zh) | 一种能调节血糖、治疗糖尿病的制剂及制备方法 | |
CN1739729A (zh) | 消渴灵制剂及其制备方法 | |
CN1368064A (zh) | 纳米益肾补骨制剂药物及其制备方法 | |
CN1150918C (zh) | 珠子参有效成份制剂及制备方法 | |
CN1053346C (zh) | 醒神剂及其制备方法 | |
CN1124144C (zh) | 复方中草药补肾袋泡茶及其制作方法 | |
CN1366948A (zh) | 纳米复方扶芳藤制剂药物及其制备方法 | |
CN1362173A (zh) | 一种纳米香砂六君制剂药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Improved method for preparing 'Zhenqi Fuzheng' medicine Effective date of registration: 20150619 Granted publication date: 20061018 Pledgee: China Cinda Asset Management Corp Gansu branch Pledgor: Gansu Fuzheng Pharmaceutical Technology Co.,Ltd. Registration number: 2015620000009 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20160712 Granted publication date: 20061018 Pledgee: China Cinda Asset Management Corp Gansu branch Pledgor: Gansu Fuzheng Pharmaceutical Technology Co.,Ltd. Registration number: 2015620000009 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Improved method for preparing 'Zhenqi Fuzheng' medicine Effective date of registration: 20160719 Granted publication date: 20061018 Pledgee: China Cinda Asset Management Corp Gansu branch Pledgor: Gansu Fuzheng Pharmaceutical Technology Co.,Ltd. Registration number: 2016620000013 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20170505 Granted publication date: 20061018 Pledgee: China Cinda Asset Management Corp Gansu branch Pledgor: Gansu Fuzheng Pharmaceutical Technology Co.,Ltd. Registration number: 2016620000013 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Improved method for preparing 'Zhenqi Fuzheng' medicine Effective date of registration: 20191231 Granted publication date: 20061018 Pledgee: Dingxi anding sub branch of Agricultural Development Bank of China Pledgor: Gansu Fuzheng Pharmaceutical Technology Co.,Ltd. Registration number: Y2019620000008 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20201231 Granted publication date: 20061018 Pledgee: Dingxi anding sub branch of Agricultural Development Bank of China Pledgor: Gansu Fuzheng Pharmaceutical Technology Co.,Ltd. Registration number: Y2019620000008 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Improvement of preparation method of Zhenqi Fuzheng medicine Effective date of registration: 20210113 Granted publication date: 20061018 Pledgee: Dingxi anding sub branch of Agricultural Development Bank of China Pledgor: Gansu Fuzheng Pharmaceutical Technology Co.,Ltd. Registration number: Y2021620000001 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220218 Granted publication date: 20061018 Pledgee: Dingxi anding sub branch of Agricultural Development Bank of China Pledgor: Gansu Fuzheng Pharmaceutical Technology Co.,Ltd. Registration number: Y2021620000001 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Improvement of preparation method of Zhenqi Fuzheng medicine Effective date of registration: 20220413 Granted publication date: 20061018 Pledgee: Dingxi anding sub branch of Agricultural Development Bank of China Pledgor: Gansu Fuzheng Pharmaceutical Technology Co.,Ltd. Registration number: Y2022620000010 |
|
CX01 | Expiry of patent term |
Granted publication date: 20061018 |
|
CX01 | Expiry of patent term |